For the quarter ending 2026-03-31, LUNG made $20,586K in revenue. -$13,845K in net income. Net profit margin of -67.25%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Revenue | 20,586 | 22,598 | 21,502 | 23,859 |
| Cost of goods sold | 4,542 | 5,057 | 5,450 | 6,655 |
| Gross profit | 16,044 | 17,541 | 16,052 | 17,204 |
| Research and development | 4,899 | 4,583 | 4,846 | 5,306 |
| Selling, general and administrative | 24,101 | 22,861 | 25,599 | 26,702 |
| Total operating expenses | 29,000 | 27,444 | 30,445 | 32,008 |
| Loss from operations | -12,956 | -9,903 | -14,393 | -14,804 |
| Interest income | 350 | 453 | 611 | 723 |
| Interest expense | 976 | 770 | 805 | 799 |
| Other income, net | 77 | -19 | 758 | -116 |
| Net loss before tax | -13,505 | -10,239 | -13,829 | -14,996 |
| Income tax expense | 149 | 186 | 128 | 177 |
| Net loss | -13,654 | -10,425 | -13,957 | -15,173 |
| Currency translation adjustment | -191 | 122 | -399 | 435 |
| Change in unrealized losses on marketable securities | 0 | 0 | 1 | -1 |
| Total other comprehensive (loss) income | -191 | 122 | -398 | 434 |
| Comprehensive loss | -13,845 | -10,303 | -14,355 | -14,739 |
| Basic EPS | -0.33 | -0.249 | -0.34 | -0.38 |
| Diluted EPS | -0.33 | -0.249 | -0.34 | -0.38 |
| Basic Average Shares | 41,897,669 | 41,422,527 | 40,936,896 | 40,429,655 |
| Diluted Average Shares | 41,897,669 | 41,422,527 | 40,936,896 | 40,429,655 |
Pulmonx Corp (LUNG)
Pulmonx Corp (LUNG)